Sheets Smith Wealth Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
SGA
WP
Sheets Smith Wealth Management's CLB Position: Q2 2017 in Review
Sheets Smith Wealth Management sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 12,245 shares — an estimated $1.42M sold.
Sheets Smith Wealth Management first reported a position in CLB in Q2 2013 and held it in 16 quarters. The position peaked at $3.56M in Q3 2014. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.
- Sheets Smith Wealth Management reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
- Sheets Smith Wealth Management sold 12,245 Core Laboratories shares in Q2 2017, an estimated $1.42M.
- Sheets Smith Wealth Management first reported a position in Core Laboratories in Q2 2013 and held it in 16 quarters.
- Sheets Smith Wealth Management's Core Laboratories position peaked at $3.56M in Q3 2014.
- 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.
Based on Sheets Smith Wealth Management's 13F filing for Q2 2017, filed 19 Jul 2017.